Status:
COMPLETED
Evaluation of Atuna Racemosa Toxicity
Lead Sponsor:
Mayo Clinic
Conditions:
Bacterial Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
For thousands of years people in the South Pacific have used Atuna racemosa extract as a topical anti-inflammatory. We, the researchers at the Mayo Clinic, have shown this extract to also have antibac...
Eligibility Criteria
Inclusion
- The subjects will be 20 healthy male and non-pregnant, non-lactating, female volunteers of ages 18 - 65. No subject will be excluded based on minority status.
Exclusion
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00318344
Start Date
April 1 2006
End Date
November 1 2007
Last Update
February 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905